Home › Cancro alla prostata › Washington
Studi clinici su Cancro alla prostata nello stato di Washington
51 studi su Cancro alla prostata cercano partecipanti presso sedi nello stato di Washington.
Città nello stato di Washington
- Seattle42 studi
- Tacoma11 studi
- Spokane Valley9 studi
- Spokane6 studi
- Kirkland5 studi
- Bellingham5 studi
- Renton5 studi
- Everett4 studi
- Walla Walla4 studi
- Vancouver4 studi
- Kennewick4 studi
- Longview4 studi
Testo ufficiale dello studio (inglese)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Washington, Fred Hutchinson Cancer Center, Seattle
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT04585750Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- e altri 19
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Valley Medical Center, Renton
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT03866382A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Swedish Medical Center, Seattle
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 28 set 2026 · NCT06095089Precision-Based Genomics in Prostate Cancer
- University of Washington, Seattle
In reclutamentoStudio osservazionale
Età da 18 a 120 · Uomini · Aggiornato il 28 set 2026 · NCT04706663Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- Fred Hutchinson Cancer Research Center, Seattle
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 25 set 2026 · NCT06801236A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Spokane Urology ( Site 0035), Spokane
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06136650A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 25 set 2026 · NCT07082920This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Northwest Medical Specialties, PLLC, Bonney Lake
- Northwest Medical Specialties, PLLC, Federal Way
- Northwest Medical Specialties, PLLC, Gig Harbor
- e altri 2
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 24 set 2026 · NCT07028853Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Fred Hutchinson Cancer Research Center, Seattle
In reclutamentoFase 2/3
Età da 18 a 100 · Uomini · Aggiornato il 22 set 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Northwest Medical Specialties, PLLC, Tacoma
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 22 set 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Swedish Medical Center, Seattle
- Northwest Medical Specialties, Tacoma
In reclutamentoFase 3
Età da 18 a 100 · Uomini · Aggiornato il 22 set 2026 · NCT06855277High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 17 set 2026 · NCT05011383Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 17 set 2026 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- VA Puget Sound Health Care System ( Site 0054), Seattle
- Fred Hutchinson Cancer Center ( Site 0060), Seattle
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 17 set 2026 · NCT06925737PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
- University of Washington Medical Center, Seattle
In reclutamentoStudio osservazionale
Età 18 e oltre · Uomini · Aggiornato il 15 set 2026 · NCT04995198The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
- University of Washington, Seattle
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 14 set 2026 · NCT06111781Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Fred Hutchinson Cancer Center, Seattle
- FHCC at Northwest Hospital, Seattle
- e altri 1
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 10 set 2026 · NCT05946213Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Investigational Site Number: 400, Seattle
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 10 set 2026 · NCT05997615Prostate Active Surveillance Study
- Veterans Affairs Puget Sound Health Care System, Seattle
- University of Washington, Seattle
In reclutamentoStudio osservazionale
Età 21 e oltre · Uomini · Aggiornato il 2 set 2026 · NCT00756665The Vanguard Study: Testing a New Way to Screen for Cancer
- Madigan Army Medical Center, Tacoma
In reclutamentoVolontari sani benvenuti
Età da 45 a 75 · Tutti i sessi · Aggiornato il 2 set 2026 · NCT06995898Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
- Fred Hutch/University of Washington Cancer Consortium, Seattle
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 27 ago 2026 · NCT07698535AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Tacoma
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 26 ago 2026 · NCT07611110A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 25 ago 2026 · NCT05593497Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- University of Washington Medical Center, Seattle
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 24 ago 2026 · NCT07745361A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
- Fred Hutchinson Cancer Center, Seattle
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 21 ago 2026 · NCT06844383Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 21 ago 2026 · NCT04221542Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- e altri 19
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 19 ago 2026 · NCT04423211A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
- Northwest Medical Specialties, PLLC - Tacoma, Tacoma
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 17 ago 2026 · NCT06842498Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 14 ago 2026 · NCT04812366Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
In reclutamentoStudio osservazionale
Età 18 e oltre · Uomini · Aggiornato il 12 ago 2026 · NCT04489719Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
In reclutamentoFase 1/2
Età 18 e oltre · Uomini · Aggiornato il 11 ago 2026 · NCT06236139A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 10 ago 2026 · NCT06067841Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
In reclutamentoFase 2
Tutte le età · Uomini · Aggiornato il 6 ago 2026 · NCT06145633Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età 18 e oltre · Uomini · Aggiornato il 6 ago 2026 · NCT01050504Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 31 lug 2026 · NCT06613100Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
- Fred Hutch/University of Washington Cancer Consortium, Seattle
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 21 lug 2026 · NCT06039371Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial
- Fred Hutch/University of Washington Cancer Consortium, Seattle
In reclutamento
Età 18 e oltre · Uomini · Aggiornato il 15 lug 2026 · NCT05918263Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Providence Regional Cancer System-Aberdeen, Aberdeen
- FHCC Overlake, Bellevue
- PeaceHealth Saint Joseph Medical Center, Bellingham
- e altri 22
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 14 lug 2026 · NCT06592924Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- University of Washington, Fred Hutchinson Cancer Center, Seattle
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 9 lug 2026 · NCT05413421Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.